News and Headlines
We invite you to review press releases announcing our recent accomplishments and articles in which we served as sources and provided legal information and insights.
Media Contacts: Darrin Schlegel: 713.653.2866 | Olivia Hoch: 305.349.2255
Healthcare Government Investigations and Audits
Clear All
Results
Showing of
23andMe Bankruptcy Sparks Genetic Data Privacy Concerns for Its 15M Customers
23andMe Bankruptcy Underscores Health Privacy Gaps
Unnecessary Surgeries Drive Rare Va. Hospital Criminal Case
Skyrocketing Medical Costs Spark Republican Pushback on Deals
Antitrust-in-Healthcare Bills Return
How a Court Ruling Could Silence Whistleblower Lawsuits
U.S. Attorney for the Middle District of Tennessee Henry Leventis Joins Holland & Knight's Nashville Office
Fake Ozempic: How Batch Numbers Help Criminal Groups Spread Dangerous Weight Loss Drugs
MultiPlan Defense Amid Price-Fixing Scrutiny Gets Boost in Court
Rural Hospitals Eye Reimbursement Boost Post-Chevron
Ex-Pharmacist Faces Rare Murder Trial in Meningitis Outbreak
Anesthesia 'Rollup' Decision May Hurry PE Regulator Suits
Healthcare Transactions Partner John Saran Joins Holland & Knight in Chicago
Holland Adds Healthcare Transactions Partner in Chicago
Healthcare Regulatory & Enforcement Partner Julia Hesse Joins Holland & Knight in Boston
The U.S. Is Flooded with Fake Botox. Here's What to Watch Out for.
HHS Underlines Consent Priority for Pelvic, Prostate Exams
Hospital 340B Drug Pricing Program Policy Reversal a 'Gut Punch'
Holland & Knight Welcomes Zubin Khambatta to Growing Healthcare Practice in Texas
SEC Cybersecurity Rule Increases Costs, Risks for Health Care
Page 1 of 2